Yatharth Hospital Board Approves Q3 Financial Results, Revenue Up

Yatharth Hospital & Trauma Care Services Limited has announced its unaudited financial results for Q3 (Oct-Dec) and the nine months ended December 31, 2025. The Board of Directors approved the results on February 5, 2026. Consolidated total income stood at ₹3,282.96 million for the quarter and ₹8,842.88 million for the nine-month period.

Financial Performance

Yatharth Hospital & Trauma Care Services Limited announced its unaudited standalone and consolidated financial results for the third quarter and nine months which ended on December 31, 2025. The board approved these results in a meeting held on February 5, 2026.

Key Financials

The company reported the following key consolidated financials:

  • Total Income for Q3: ₹3,282.96 million
  • Total Income for the nine months: ₹8,842.88 million
  • Profit after tax for Q3: ₹430.83 million
  • Profit after tax for the nine months: ₹1,263.75 million

Subsidiary Performance

The consolidated statement includes the performance of the holding company and its subsidiaries. Total revenues for subsidiaries not reviewed by Yatharth’s auditor were ₹653.16 million for the quarter and ₹1,556.17 million for the nine months ended December 31, 2025.

Business Updates

The company acquired a hospital in Agra, Uttar Pradesh effective February 1, 2026, increasing its operational bed capacity.

QIP Proceeds Utilization

The company has utilized its Qualified Institutional Placement (QIP) proceeds towards several strategic objectives:

  • Repayment of borrowings: ₹956.80 million
  • Hospital acquisition in Delhi and Faridabad: ₹2,173.85 million
  • Purchase of medical equipment: ₹1,129.70 million

Source: BSE

Previous Article

Alembic Pharmaceuticals Q3 FY26 Revenue Up 11%, Focus on Growth

Next Article

Alembic Pharmaceuticals Investor Presentation on Unaudited Financial Results for Q3 2026